The efficiency of progesterone vaginal gel versus intramuscular progesterone for luteal phase supplementation in gonadotropin-releasing hormone antagonist cycles: a prospective clinical trial
- PMID: 19939363
- DOI: 10.1016/j.fertnstert.2009.10.004
The efficiency of progesterone vaginal gel versus intramuscular progesterone for luteal phase supplementation in gonadotropin-releasing hormone antagonist cycles: a prospective clinical trial
Abstract
We compared the efficiency of progesterone vaginal gel (PVG) with intramuscular progesterone (IMP) supplementation for luteal phase support after in vitro fertilization and embryo transfer in gonadotropin-releasing hormone (GnRH) antagonist cycles. The treatment outcomes were similar for PVG and IMP for luteal support in GnRH-antagonist protocols. With its ease of use, high tolerability by patients, and fewer side effects, PVG can be a successful alternative to IMP.
Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Comment in
-
Progesterone administration route in gonadotropin-releasing hormone antagonist cycles.Fertil Steril. 2010 Aug;94(3):e47; author reply e48. doi: 10.1016/j.fertnstert.2010.04.014. Fertil Steril. 2010. PMID: 20627239 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources